Cargando…

Severe Hypothyroidism Complicated by Myopathy and Neuropathy with Atypical Demyelinating Features

Autoimmune hypothyroidism may result in a wide range of neuromuscular disorders. The frequently observed neurological manifestations of acquired hypothyroidism include mild to moderate myopathy and sensorimotor neuropathy, which usually resolve by clinical and electrophysiological criteria, in adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Brzozowska, Malgorzata Monika, Banthia, Shraddha, Thompson, Simon, Narasimhan, Manisha, Lee, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159635/
https://www.ncbi.nlm.nih.gov/pubmed/34104497
http://dx.doi.org/10.1155/2021/5525156
_version_ 1783700130952642560
author Brzozowska, Malgorzata Monika
Banthia, Shraddha
Thompson, Simon
Narasimhan, Manisha
Lee, James
author_facet Brzozowska, Malgorzata Monika
Banthia, Shraddha
Thompson, Simon
Narasimhan, Manisha
Lee, James
author_sort Brzozowska, Malgorzata Monika
collection PubMed
description Autoimmune hypothyroidism may result in a wide range of neuromuscular disorders. The frequently observed neurological manifestations of acquired hypothyroidism include mild to moderate myopathy and sensorimotor neuropathy, which usually resolve by clinical and electrophysiological criteria, in adults treated with thyroid hormone replacement. We report a case of a 30-year-old male with severe hypothyroidism secondary to chronic autoimmune thyroiditis who presented with a 2-year history of progressive fatigue, upper and lower limb weakness, myalgia, and intermittent paraesthesia. His neurological exam demonstrated proximal and distal muscle weakness, lower limb areflexia, and relatively intact sensory modalities. The patient's biochemistry revealed unusually and profoundly raised the thyroid stimulating hormone (TSH) level of 405.5 mIU/L (reference range (RR): 0.27–4.2 mIU/L) and creatine kinase (CK) level of 20,804 U/L (RR: 45–250 U/L), while his nerve conduction studies (NCS) demonstrated severe sensorimotor polyneuropathy with both axonal and demyelinating features. Thyroid hormone replacement therapy over the first 3 months resulted in biochemical normalization of his extremely deranged thyroid function tests (TFTs) and CK levels. At 12 months, despite maintaining euthyroidism and noticeable improvement in strength, his nerve conduction studies (NCS) demonstrated the continued absence of distal motor and sensory responses in his lower limbs with only partial improvement in sensory amplitudes and conduction velocities in his upper limbs. This report highlights the potential for severe neuromuscular consequences from advanced and chronic autoimmune hypothyroidism. The patient's myopathy has resolved over a period of three months with prompt normalization of CK levels. Concerningly, the patient achieved significant but incomplete recovery from his mixed axonal and demyelinating neuropathy with residual mild distal weakness and areflexia in his lower limbs and persistent motor and sensory impairments on his NCS. The severity and incomplete resolution of our patient's neurological manifestations emphasize the importance of early diagnosis and the need for prompt therapeutic intervention for hypothyroidism.
format Online
Article
Text
id pubmed-8159635
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-81596352021-06-07 Severe Hypothyroidism Complicated by Myopathy and Neuropathy with Atypical Demyelinating Features Brzozowska, Malgorzata Monika Banthia, Shraddha Thompson, Simon Narasimhan, Manisha Lee, James Case Rep Endocrinol Case Report Autoimmune hypothyroidism may result in a wide range of neuromuscular disorders. The frequently observed neurological manifestations of acquired hypothyroidism include mild to moderate myopathy and sensorimotor neuropathy, which usually resolve by clinical and electrophysiological criteria, in adults treated with thyroid hormone replacement. We report a case of a 30-year-old male with severe hypothyroidism secondary to chronic autoimmune thyroiditis who presented with a 2-year history of progressive fatigue, upper and lower limb weakness, myalgia, and intermittent paraesthesia. His neurological exam demonstrated proximal and distal muscle weakness, lower limb areflexia, and relatively intact sensory modalities. The patient's biochemistry revealed unusually and profoundly raised the thyroid stimulating hormone (TSH) level of 405.5 mIU/L (reference range (RR): 0.27–4.2 mIU/L) and creatine kinase (CK) level of 20,804 U/L (RR: 45–250 U/L), while his nerve conduction studies (NCS) demonstrated severe sensorimotor polyneuropathy with both axonal and demyelinating features. Thyroid hormone replacement therapy over the first 3 months resulted in biochemical normalization of his extremely deranged thyroid function tests (TFTs) and CK levels. At 12 months, despite maintaining euthyroidism and noticeable improvement in strength, his nerve conduction studies (NCS) demonstrated the continued absence of distal motor and sensory responses in his lower limbs with only partial improvement in sensory amplitudes and conduction velocities in his upper limbs. This report highlights the potential for severe neuromuscular consequences from advanced and chronic autoimmune hypothyroidism. The patient's myopathy has resolved over a period of three months with prompt normalization of CK levels. Concerningly, the patient achieved significant but incomplete recovery from his mixed axonal and demyelinating neuropathy with residual mild distal weakness and areflexia in his lower limbs and persistent motor and sensory impairments on his NCS. The severity and incomplete resolution of our patient's neurological manifestations emphasize the importance of early diagnosis and the need for prompt therapeutic intervention for hypothyroidism. Hindawi 2021-05-19 /pmc/articles/PMC8159635/ /pubmed/34104497 http://dx.doi.org/10.1155/2021/5525156 Text en Copyright © 2021 Malgorzata Monika Brzozowska et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Brzozowska, Malgorzata Monika
Banthia, Shraddha
Thompson, Simon
Narasimhan, Manisha
Lee, James
Severe Hypothyroidism Complicated by Myopathy and Neuropathy with Atypical Demyelinating Features
title Severe Hypothyroidism Complicated by Myopathy and Neuropathy with Atypical Demyelinating Features
title_full Severe Hypothyroidism Complicated by Myopathy and Neuropathy with Atypical Demyelinating Features
title_fullStr Severe Hypothyroidism Complicated by Myopathy and Neuropathy with Atypical Demyelinating Features
title_full_unstemmed Severe Hypothyroidism Complicated by Myopathy and Neuropathy with Atypical Demyelinating Features
title_short Severe Hypothyroidism Complicated by Myopathy and Neuropathy with Atypical Demyelinating Features
title_sort severe hypothyroidism complicated by myopathy and neuropathy with atypical demyelinating features
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159635/
https://www.ncbi.nlm.nih.gov/pubmed/34104497
http://dx.doi.org/10.1155/2021/5525156
work_keys_str_mv AT brzozowskamalgorzatamonika severehypothyroidismcomplicatedbymyopathyandneuropathywithatypicaldemyelinatingfeatures
AT banthiashraddha severehypothyroidismcomplicatedbymyopathyandneuropathywithatypicaldemyelinatingfeatures
AT thompsonsimon severehypothyroidismcomplicatedbymyopathyandneuropathywithatypicaldemyelinatingfeatures
AT narasimhanmanisha severehypothyroidismcomplicatedbymyopathyandneuropathywithatypicaldemyelinatingfeatures
AT leejames severehypothyroidismcomplicatedbymyopathyandneuropathywithatypicaldemyelinatingfeatures